Serabelisib
Serabelisib Uses, Dosage, Side Effects, Food Interaction and all others data.
Serabelisib is under investigation in clinical trial NCT02625259 (A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-117 (MLN1117) in Healthy Participants).
| Trade Name | Serabelisib |
| Generic | Serabelisib |
| Serabelisib Other Names | Serabelisib |
| Type | |
| Formula | C19H17N5O3 |
| Weight | Average: 363.377 Monoisotopic: 363.133139427 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Serabelisib
